PPARGC1A and metabolic dysfunction-associated steatotic liver disease: In this regard, an observational study by Pirola et al., suggested that the 5hmC might be involved in the pathogenesis of NAFLD by regulating liver mitochondrial biogenesis and PPARγ coactivator 1a (PGC-1α) expression [50].